[Hub]/) : Traits : Medication: Levothyroxine sodium :

chr8:8,092,025-8,939,373

Best TWAS P=2.94e-10 · Best GWAS P=7.18e-12 conditioned to 1

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Brain Cerebellar Hemisphere FAM86B3P 0.28 0.27 lasso 8 0.28 5.4e-08 -6.5 6.0 1.7e-09 -0.83 0.06 0.93 FALSE
2 GTEx Brain Cerebellum FAM86B3P 0.19 0.14 lasso 5 0.16 1.8e-05 -5.4 5.7 9.8e-09 -0.85 0.07 0.92 FALSE
3 GTEx Brain Cortex FAM86B3P 0.14 0.05 enet 9 0.07 5.1e-03 -5.5 5.3 8.9e-08 -0.80 0.04 0.84 FALSE
4 GTEx Brain Frontal Cortex BA9 FAM86B3P 0.16 0.13 enet 27 0.10 1.1e-03 -5.6 5.4 8.0e-08 -0.72 0.08 0.81 FALSE
5 GTEx Cells Transformed fibroblasts FAM86B3P 0.23 0.33 lasso 11 0.38 8.4e-30 -4.9 -5.7 1.2e-08 0.82 0.65 0.35 FALSE
6 GTEx Colon Transverse FAM86B3P 0.13 0.04 lasso 8 0.04 4.4e-03 -5.4 -5.3 1.2e-07 0.78 0.12 0.58 FALSE
7 GTEx Esophagus Mucosa FAM86B3P 0.22 0.17 lasso 8 0.19 1.7e-12 -4.9 -5.8 5.8e-09 0.80 0.67 0.33 FALSE
8 GTEx Testis FAM86B3P 0.15 0.14 lasso 7 0.13 2.2e-06 -5.5 5.6 2.4e-08 -0.78 0.17 0.83 FALSE
9 GTEx Thyroid SGK223 0.19 0.35 enet 16 0.36 1.1e-28 -6.8 6.3 2.9e-10 -0.95 0.00 1.00 TRUE
10 ROSMAP Brain Pre-frontal Cortex FAM86B3P 0.19 0.27 bslmm 331 0.27 5.6e-35 -5.5 5.2 1.6e-07 -0.65 0.87 0.13 FALSE
11 ROSMAP Brain Pre-frontal Cortex FAM85B 0.16 0.23 enet 18 0.22 1.8e-28 -4.9 5.3 1.2e-07 -0.79 0.97 0.03 FALSE
12 The Cancer Genome Atlas Bladder Urothelial Carcinoma FLJ10661 0.10 0.16 lasso 1 0.15 6.1e-13 -5.4 -5.4 5.4e-08 0.74 0.02 0.98 FALSE
13 The Cancer Genome Atlas Colon Adenocarcinoma FLJ10661 0.15 0.26 lasso 4 0.23 3.0e-13 -5.4 -5.5 4.8e-08 0.76 0.02 0.98 FALSE
14 The Cancer Genome Atlas Esophageal Carcinoma FLJ10661 0.20 0.23 lasso 2 0.23 5.6e-08 -5.6 -5.5 4.2e-08 0.74 0.01 0.99 FALSE
15 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma FLJ10661 0.07 0.14 lasso 3 0.14 3.7e-15 -5.4 -5.5 3.9e-08 0.75 0.02 0.98 FALSE
16 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma FLJ10661 0.07 0.02 blup 42 0.04 2.9e-03 -4.8 -5.8 6.8e-09 0.75 0.02 0.79 FALSE
17 The Cancer Genome Atlas Brain Lower Grade Glioma FLJ10661 0.21 0.26 lasso 9 0.30 2.3e-34 -4.9 5.3 1.2e-07 -0.77 0.04 0.95 FALSE
18 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma FLJ10661 0.11 0.06 enet 5 0.07 2.3e-05 -5.4 -5.1 2.8e-07 0.70 0.01 0.95 FALSE
19 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma FLJ10661 0.25 0.18 lasso 4 0.16 4.2e-07 -5.6 5.9 4.7e-09 -0.76 0.00 0.99 FALSE
20 The Cancer Genome Atlas Soft Tissue Sarcoma FLJ10661 0.12 0.00 blup 42 0.00 6.9e-01 -5.4 -6.0 1.7e-09 0.64 0.01 0.51 FALSE
21 The Cancer Genome Atlas Stomach Adenocarcinoma FLJ10661 0.08 0.05 blup 42 0.07 9.3e-06 -4.8 -5.7 1.0e-08 0.75 0.02 0.98 FALSE
22 The Cancer Genome Atlas Testicular Germ Cell Tumors FLJ10661 0.24 0.36 enet 8 0.35 4.1e-13 -5.4 -5.5 3.7e-08 0.75 0.02 0.98 FALSE
23 The Cancer Genome Atlas Thyroid Carcinoma SGK223 0.16 0.20 enet 14 0.22 6.1e-21 4.1 5.3 1.3e-07 -0.77 0.82 0.17 FALSE